Sign in

CIK 0001649904

  • Large accelerated filer

RHYTHM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RYTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
462159271
Phone
+1 857-264-4280
Business address
222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
Former names
RHYTHM METABOLIC, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,753,355
in 2 filings, $11.8M under 10b5-1 plans

Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-27 Shulman Joseph Chief Technical Officer Sale 10b5-1 −5,015 $50.01 $251K 1,126
2023-12-27 Shulman Joseph Chief Technical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −2,400 82,600
2023-12-06 Smith Hunter C Chief Financial Officer Option exercise +20,000 $6.88 $138K 81,406
2023-12-06 Smith Hunter C Chief Financial Officer Sale −20,000 $40.00 $800K 61,406
2023-12-06 Smith Hunter C Chief Financial Officer Option exercise · Stock Option (Right to Buy) −20,000 111,094
2023-12-05 Smith Hunter C Chief Financial Officer Option exercise +7,026 $6.88 $48K 68,432
2023-12-05 Smith Hunter C Chief Financial Officer Sale −7,026 $35.06 $246K 61,406
2023-12-05 Smith Hunter C Chief Financial Officer Option exercise · Stock Option (Right to Buy) −7,026 131,094
2023-11-24 Smith Hunter C Chief Financial Officer Option exercise +10,974 $6.88 $76K 72,380
2023-11-24 Smith Hunter C Chief Financial Officer Sale −10,974 $35.02 $384K 61,406
2023-11-24 Smith Hunter C Chief Financial Officer Option exercise · Stock Option (Right to Buy) −10,974 138,120
2023-11-14 Shulman Joseph Chief Technical Officer Option exercise 10b5-1 +27,890 $6.80 $190K 31,631
2023-11-14 Shulman Joseph Chief Technical Officer Sale 10b5-1 −27,890 $32.07 $894K 3,741
2023-11-14 Shulman Joseph Chief Technical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −27,890 35,860
2023-11-14 Lee Jennifer Kayden EVP, Head of North America Option exercise 10b5-1 +12,030 $6.80 $82K 13,677
2023-11-14 Lee Jennifer Kayden EVP, Head of North America Sale 10b5-1 −13,677 $32.01 $438K 0
2023-11-14 Lee Jennifer Kayden EVP, Head of North America Option exercise · Stock Option (Right to Buy) 10b5-1 −12,030 46,412
2023-11-14 Smith Hunter C Chief Financial Officer Option exercise +12,000 $6.88 $83K 73,406
2023-11-14 Smith Hunter C Chief Financial Officer Sale −12,000 $30.38 $365K 61,406
2023-11-14 Smith Hunter C Chief Financial Officer Option exercise · Stock Option (Right to Buy) −12,000 149,094

Page 32 of 36 · 701 trades